Chesire-based international veterinary drugs giant Dechra Pharmaceuticals announced that following a comprehensive search process Alison Platt will be appointed as its chair with effect from January 1, 2022.

Tony Rice will step down from the board on December 31, 021.

Platt joined the Dechra board as a non-executive director in March, 2020, and has extensive board experience gained in non-executive roles at Bupa Arabia, Cable & Wireless, Skills for Health and the Foreign and Commonwealth Office.

She is currently a non-executive director at Tesco, Spectrum Life and chair of Legal & General Financial Advice.

Dechra also announced that Denise Goode, non-executive director, has informed the board that due to other commitments she has decided to tender her resignation and step down from the board and leaves the company on November 30, 2021.

Julian Heslop will re-assume the role of audit committee chairman until a successor is appointed.

Dechra CEO Ian Page said: “I am delighted that Alison has accepted the chair following Tony’s retirement at the end of the year.

“I look forward to working with Alison in her new role.

“Since joining us as a non-executive director in 2020 Alison has gained a good understanding of Dechra and our culture.

“Her extensive leadership experience and skills will further enhance the team’s capabilities.

“I would also like to acknowledge Tony’s contribution to the development of the group. We wish him all the best.”